REG - MyHealthChecked PLC - Results of AGM and Share Consolidation

MyhealthcheckedAnnouncement

11/05/2023 11:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230511:nRSK1317Za&default-theme=true

RNS Number : 1317Z  MyHealthChecked PLC  11 May 2023

MyHealthChecked PLC

("MyHealthChecked" or the "Company")

 

Results of Annual General Meeting and Share Consolidation

 

MyHealthChecked PLC (AIM: MHC), the consumer home-testing healthcare company,
is pleased to announce that at the Annual General Meeting of the Company held
earlier today (the "Annual General Meeting"), all resolutions put to the
Company's shareholders ("Shareholders") were duly passed.

 

 Resolution                        Votes for(1)  % of shares voted(2)  Votes against(3)  % of shares voted

 (*indicates special resolution)
 Resolution 1                      204,958,197   99.56%                900,830           0.44%

 Resolution 2                      204,500,059   99.36%                1,313,830         0.64%

 Resolution 3                      204,389,188   99.33%                1,373,108         0.67%

 Resolution 4                      204,389,188   99.33%                1,373,108         0.67%

 Resolution 5                      200,495,999   97.44%                5,266,297         2.56%

 Resolution 6                      173,511,875   84.30%                32,305,086        15.70%

 Resolution 7*                     173,231,351   84.18%                32,543,888        15.82%

 Resolution 8                      176,698,162   85.86%                29,110,675        14.14%

 Resolution 9*                     173,000,463   84.06%                32,808,374        15.94%

 Resolution 10*                    173,336,748   84.21%                32,498,793        15.79%

 

Notes :

(1)( )Any proxy appointments which gave discretion to the Chairman have been
included in the "for" total.

(2)( )As a percentage of the aggregate of votes "for" plus votes "against".

(3)( )An abstention is not counted towards the votes cast "for" or "against"
a resolution.

 

The full text of, inter alia, the resolutions proposed and passed at the
Annual General Meeting can be found in the Company's Shareholder Circular and
Notice of Annual General Meeting (the "Circular") which was published and
posted to Shareholders on 3 April 2023 and is available on the Company's
website at https://investors.myhealthchecked.com/
(https://investors.myhealthchecked.com/)

 

 

 

Share Consolidation

At the Annual General Meeting, Shareholders approved, inter alia, the Share
Consolidation, as detailed in the Circular.

 

The Share Consolidation consists of a consolidation of the ordinary shares of
£0.001 each in the capital of the Company (the "Ordinary Shares"), such that
every 15 Ordinary Shares will be consolidated into one new ordinary share of
£0.015 nominal value each (the "Consolidated Ordinary Shares").

 

Following the Share Consolidation, the Company will have a single class of
ordinary shares of £0.015 each in issue, being the Consolidated Ordinary
Shares.

 

Admission of the Consolidated Ordinary Shares to trading on AIM

Application has been made to the London Stock Exchange plc for the admission
to trading on AIM of the Consolidated Ordinary Shares, which is expected to
become effective and dealings commence at 8.00 a.m. on or around 12 May 2023
(the "Consolidation Admission").

 

Total Voting Rights, ISIN, SEDOL and Par Value

The Consolidated Ordinary Shares have a new ISIN and SEDOL code, and the
number of total voting rights in the Company's issued ordinary share capital
will decrease as a result of the Share Consolidation.

 

Accordingly, upon the Consolidation Admission, the Company's issued share
capital will consist of 52,005,932 Consolidated Ordinary Shares each with one
voting right. The Company does not hold any ordinary shares in treasury. This
figure may be used by Shareholders in the Company as the denominator for the
calculation by which they may determine if they are required to notify their
interest in, or change to their interest in, the share capital of the Company
under the FCA's Disclosure Guidance and Transparency Rules. In addition, the
ISIN and SEDOL code of the Consolidated Ordinary Shares will be GB00BN7K5L93
and BN7K5L9, respectively.

 

Unless otherwise defined, capitalised terms used in this announcement have the
same meanings as ascribed to them in the Circular sent to Shareholders dated 3
April 2023.

 

This announcement contains inside information for the purposes of Article 7 of
the Market Abuse Regulation (EU) 596/2014, as it forms part of UK domestic law
by virtue of the European Union (Withdrawal) Act 2018, as amended.

 

For further information contact:

 

 MyHealthChecked PLC                                                www.myhealthchecked.com (http://www.myhealthchecked.com)
 Penny McCormick, Chief Executive Officer                           via Walbrook PR

 SPARK Advisory Partners Limited (NOMAD)                            Tel: +44 (0)20 3368 3550
 Neil Baldwin

 Dowgate Capital Limited (Broker)                                   Tel: +44 (0)20 3903 7715
 David Poutney / Nicholas Chambers

 Walbrook PR Ltd (Media & IR)      Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com
 Paul McManus / Alice Woodings                                      Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654

 

About MyHealthChecked PLC (www.myhealthcheckedplc.com
(http://www.myhealthcheckedplc.com) )

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK
healthcare company focused on a range of at-home healthcare and wellness
tests.

 

MyHealthChecked (http://www.myhealthchecked.com) is the umbrella brand of a
range of at-home rapid tests, as well as DNA, RNA and blood sample collection
kits which have been created to support customers on their journeys to
wellness. The tests are lateral-flow self-tests, and the sample collection
kits enable the collection of blood, urine nasal or mouth swab samples that
are analysed in partner laboratories for a range of biomarkers. The tests will
also be made available online and will be viable for over-the -counter
purchase.

 

The MyHealthChecked portfolio has been identified as part of a change in
mindset as customers become more familiar with the concept of accessible
healthcare in the growing at home testing kit market with a focus on
accessibility at the right price, led by UK-based experts.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGMZGMKGMRGFZM